Business & Tech
Weston Firm Seeks Approval for New Drug
The drug would be used to treat multiple sclerosis.
Weston-based Biogen Idec is seeking approval from the federal government for its new Multiple Sclerosis drug, according to the Boston Herald.
The drug, designed to treat relapsing forms of the condition, comes after one year of study of the medication. The data showed the drug greatly reduced relapses and disability progression. The drug, which is injectible, is called Plegridy.
The company said it anticipates hearing of the possible acceptance of the drug within the next few months.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
We’ve removed the ability to reply as we work to make improvements. Learn more here
